CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study (2023) Kang EY, Weir A, Meagher NS, Farrington K, Nelson GS, Ghatage P, Lee CH, et al. Journal article Trauma and sporadic desmoid tumor development – an approach toward real incidence and aspects of causality (2023) Hohenberger P, Menge F, Hohenberger R, Kasper B, Marx A, Haller F, Baumgarten C, et al. Journal article Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network (2021) Gay F, Guenther A, Offidani M, Engelhardt M, Salvini M, Montefusco V, Patriarca F, et al. Journal article Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors: A pooled analysis from the randomized, phase 3 RADIANT-3 and RADIANT-4 trials (2021) Fazio N, Carnaghi C, Buzzoni R, Valle JW, Herbst F, Ridolfi A, Strosberg J, et al. Journal article Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience (2020) Hol JA, Jongmans MCJ, Sudour-Bonnange H, Ramirez-Villar GL, Chowdhury T, Rechnitzer C, Pal N, et al. Journal article The BiTE (bispecific T-cell engager) platform: Development and future potential of a targeted immuno-oncology therapy across tumor types (2020) Einsele H, Borghaei H, Orlowski RZ, Subklewe M, Roboz GJ, Zugmaier G, Kufer P, et al. Journal article, Review article Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases (2020) Popp I, Rau S, Hintz M, Schneider J, Bilger A, Fennell JT, Heiland DH, et al. Journal article Current developments in immunotherapy in the treatment of multiple myeloma (2018) Koehler M, Greil C, Hudecek M, Lonial S, Raje N, Waesch R, Engelhardt M Journal article, Review article Single-cycle induction chemotherapy followed by chemoradiotherapy or surgery in patients with head and neck cancer: What are the best predictors of remission and prognosis? (2015) Semrau S, Haderlein M, Schmidt D, Lell M, Wolf W, Waldfahrer F, Uder M, et al. Journal article Downstage migration after neoadjuvant chemoradiotherapy for rectal cancer: the reverse of the Will Rogers phenomenon? (2015) Fokas E, Liersch T, Fietkau R, Hohenberger W, Hess C, Becker H, Sauer R, et al. Journal article